Organization | University of Oxford

University of Oxford Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Oxford England United Kingdom (1096)

Organization Overview

First Clinical Trial

1983

NCT00222664

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

Balliol College Oxford | Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom | Centre for Human Genetics, University of Oxford | Churchill Hospital | Churchill Hospital, Oxford, UK | Churchill Hospital, Oxford, United Kingdom | Clinical Trial Service Unit (CTSU), University of Oxford | Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford | Clinical Trial service Unit, University of Oxford | Clinical Trial Service Unit, University of Oxford | Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford | Department of Oncology, University of Oxford | Department of Paediatrics, Oxford University | Dept. Clinical Immunology, Oxford Radcliffe Hospitals | Dept. Psychiatry, University of Oxford | Diabetes Trials Unit, University of Oxford | Director, The Jenner Institute, Oxford University | Dr Paola Cicconi | Eijkman-Oxford Clinical Research Unit, Oxford University | Global Health - Oxford University Siena University | Jenner Institute | Jenner Institute, University of Oxford | John Radcliffe Hospital, Oxford, UK | KEMRI Centre for Geographic Medicine Research (Coast), University of Oxford, England | KEMRI Wellcome Trust Research Programme and University of Oxford | KEMRI-Wellcome Trust Research Programme, University of Oxford | KEMRI/Wellcome Trust Research Programme & University of Oxford | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU) | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU), Laos | Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead) | Mountain Medicine Society of Nepal (MMSN), Nepal International Clinic (NIC) and Oxford University Clinical Research Unit (OUCRU), Kathmandu, Nepal | MRC Human Immunology Unit, John Radcliffe Hospital, University of Oxford, OX3 9DS UK | NHS Blood and Transplant, Oxford, United Kingdom | Nuffield Department of Clinical Neurosciences | Nuffield Department of Clinical Neurosciences, Oxford (UOXF) | Nuffield Department of Medicine, University of Oxford, UK | Nuffield Department of Obstetrics and Gynaecology, University of Oxford | Nuffield Dept of Clinical Medicine, University of Oxford | Oxford Cancer & Haematology Centre, The Churchill Hospital, Old Road - Headington, Oxford, OX3 7LE Email: ronjon.chakraverty@ndcls.ox.ac.uk | Oxford Centre for Enablement, Oxford University Hospitals NHS FT, Windmill Road, Oxford OX3 7HE, United Kingdom | Oxford Clinical Trials Research Unit | Oxford Clinical Trials Research Unit (OCTRU) | Oxford-Emergent Tuberculosis Consortium | Oxford Eye Hospital | Oxford Haemophilic Centre and Thrombosis Unit, Churchill Hospital | Oxford Health NHS Foundation Trust | Oxford Radcliffe Hospitals Trust | Oxford Radcliffe NHS Trust & University of Oxford | Oxford Radcliffe NHS Trust, University of Oxford | Oxford Radclifffe Hospitals NHS Trust | Oxford Research | Oxford University | Oxford University Clinical Research Unit | Oxford University Clinical Research Unit, Vietnam | Oxford University Hospital NHS Trust | Oxford University Hospitals | Oxford University Hospitals NHS Trust | Oxford University Hospitals Trust | Oxford University Hospitals Trust, John Radcliffe Hospital, Oxford, UK, | Oxford University, KEMRI-Wellcome Trust | Oxford University of Clinical Research | Oxford University, UK | Oxford Vaccine Group | Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Churchill Hospital | Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford OX3 7LJ | Oxford Vaccine Group, Chief Investigator | Oxford Vaccine Group, Department of Paediatrics, University of Oxford | Oxford Vaccine Group, The University of Oxford | Oxford Vaccine Group, University of Oxford | Pain Research & Nuffield Department of Anaesthetics - University of Oxford | Pain Research & Nuffield Division of Anaesthesics, Department of Clinical Neurosciences, University of Oxford. The Churchill, Oxford OX3 7LJ (United Kingdom) | The Churchill Hospital, Oxford, UK | The Jenner Institute, University of Oxford | The Oxford University Hospitals NHS Trust | The University of Oxford | Univeristy of Oxford | Universitiy of Oxford & Kenya Medical Research Institute | University of Oxford | University of Oxford and Oxford Radcliffe NHS Trust | University of Oxford (at the time of study); MRC Cognition and Brain Sciences unit (current) | University of Oxford; Centre for Vaccinology & Tropical Medicine | University of Oxford, Clinical Vaccine Research and Immunisation Education | University of Oxford Department of Oncology, Churchill Hospital | University of Oxford, Department of Paediatrics | University of Oxford. Department of Paediatrics | University of Oxford, Departmentof Psychiatry, UK | University of Oxford, John Radcliffe Hospital | University of Oxford & KEMRI-Wellcome Trust | University of Oxford, Medical Sciences Division, Department of Psychiatry | University of Oxford, Oxford Radcliffe Hospitals NHS Trust and Moorfields Eye Hospital | University of Oxford, UK | Warneford Hospital, Oxford | Wellcome Centre for Integrative Neuroimaging

University of Oxford Report issue

Drugs in Phase 4 Trials (114)

Drugs in Phase 3 Trials (82)

Drugs in Phase 2 Trials (177)

Drugs in Phase 1 Trials (71)

Drugs in Other Trials (62)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview